IMPORTANT SAFETY INFORMATION: STIVARGA can cause liver problems, which can be serious and sometimes lead to death. Your healthcare provider will do blood tests... Continue reading below
Bayer logo

Helping you get and pay for your medicine

Because STIVARGA® (regorafenib) is a specialized anticancer medicine, it is not available at retail pharmacies. You can get your medicine in 3 easy ways:

3 Ways to Get STIVARGA
REACH®
By accessing REACH® (Resources for Expert Assistance and Care Helpline). The REACH program provides you with nursing support and trusted guidance on taking STIVARGA, as well as financial assistance services
Call 1-866-639-2827 to contact a REACH counselor today
SPPs
Through a network of specialty pharmacy providers (SPPs). SPPs help new patients start on therapy, provide access to counselors, and ensure fast, reliable delivery of prescriptions
Doctor's Office
At your doctor’s office, if an on-site pharmacy is available
REACH patient program
Blue caret
Access to STIVARGA
Blue caret
$0 Co-Pay program*
Blue caret

Did you know that Bayer provides financial support to eligible patients?

Privately Insured*

Call 1-866-581-4992

for more information
on enrolling online

Learn More

Government Insured

(eg, Medicare, Medicaid, Military)

  • Information on Part D
    prescription drug plans
  • Financial assistance may be
    available through independent
    charitable organizations
  • Alternate funding options

Call 1-866-639-2827

to speak with a reimbursement counselor (9am-5pm EST/EDT)

Learn More

Uninsured/Underinsured

  • Patient Assistance Program (PAP)
  • Eligibility requirements apply
  • Up to 12 months of free drug for qualified patients
  • Alternate funding options

Call 1-866-639-2827

to speak with a reimbursement counselor (9am-5pm EST/EDT)

Learn More

You may be eligible!

Check with your doctor, REACH counselor, or your Specialty Pharmacy Provider (SPP) to see if you qualify for $0 Co-Pay* assistance.


*Patients who are enrolled in any type of government insurance or reimbursement programs are not eligible. As a condition precedent of the co-payment support provided under this program, e.g., co-pay refunds, participating patients and pharmacies are obligated to inform insurance companies and third-party payors of any benefits they receive and the value of this program, as required by contract or otherwise. Void where prohibited by law, taxed, or restricted. Patients enrolled in Bayer’s Patient Assistance Program are not eligible. Bayer may determine eligibility, monitor participation, equitably distribute product, and modify or discontinue any aspect of the REACH program at any time, including but not limited to this commercial co-pay assistance program.

Indications

STIVARGA® (regorafenib) is a prescription medicine used to treat people with:

It is not known if STIVARGA is safe and effective in children less than 18 years of age.

Important Safety Information

STIVARGA (regorafenib) can cause liver problems, which can be serious and sometimes lead to death. Your healthcare provider will do blood tests to check your liver function before you start taking STIVARGA and during your treatment with STIVARGA to check for liver problems. Tell your healthcare provider right away if you experience yellowing of your skin or the white part of your eyes, nausea, vomiting, dark urine, or change in your sleep pattern.

Before taking STIVARGA, tell your healthcare provider about all of your medical conditions, including if you:

Tell your healthcare provider about all the prescription and over-the-counter medicines, vitamins, and herbal supplements you take. Avoid drinking grapefruit juice and taking St. John’s Wort while taking STIVARGA.

STIVARGA may cause serious side effects, including:

The most common side effects with STIVARGA include pain including stomach-area (abdomen); tiredness, weakness, fatigue; diarrhea (frequent or loose bowel movements); decreased appetite; infection; voice change or hoarseness; increase in certain liver function tests; fever; swelling, pain, and redness of the lining in your mouth, throat, stomach, and bowel (mucositis); and weight loss

For important risk and use information about STIVARGA, please see the full Prescribing Information, including Boxed Warning.

You are encouraged to report negative side effects or quality complaints of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.